27th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180185270 | MUCOSAL DELIVERY OF VITAMIN B12 | 2018-07-05 |
20180185271 | ORODISPERSIBLE TABLET CONTAINING ESTETROL | 2018-07-05 |
20180185272 | SYNTHESIS AND APPLICATION OF MICROBUBBLE-FORMING COMPOUNDS | 2018-07-05 |
20180185273 | CORE-SHELL STRUCTURE AND TOPICAL AGENT | 2018-07-05 |
20180185274 | LOW FREQUENCY GLATIRAMER ACETATE THERAPY | 2018-07-05 |
20180185275 | MEMBRANE-ADHERENT SELF-ASSEMBLED SYSTEMS FOR TREATMENT OF OCULAR DISORDERS | 2018-07-05 |
20180185276 | CONTACT LENSES CARRYING MITOCHONRIALLY-TARGETED ANTIOXIDANTS | 2018-07-05 |
20180185277 | OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE ESOPHAGUS | 2018-07-05 |
20180185278 | COMPOSITIONS CONTAINING PREEN OIL AND METHODS OF USE THEREOF | 2018-07-05 |
20180185279 | Bendamustine Solid Dispersions And Continuous Infusion | 2018-07-05 |
20180185280 | PROPOFOL EMULSION FOR PARENTERAL ADMINISTRATION | 2018-07-05 |
20180185281 | DRUG DELIVERY CARRIER, AND COMPOSITION CONTAINING SAME | 2018-07-05 |
20180185282 | CURCUMIN-LOADED NANOEMULSIONS, METHOD OF MANUFACTURE, AND METHOD OF PREVENTIVE TREATMENT USING THE SAME | 2018-07-05 |
20180185283 | NON-RINSE CHEMICAL MOUSSE CONTAINING ADAPALENE AND BENZOYL PEROXIDE | 2018-07-05 |
20180185284 | Nanoliposomal c-MYC-siRNA Inhibits In Vivo Tumor Growth of Cisplatin-Resistant Ovarian Cancer | 2018-07-05 |
20180185285 | Milk-Derived Microvesicle Compositions and Related Methods | 2018-07-05 |
20180185286 | POROUS MATERIALS CONTAINING COMPOUNDS INCLUDING PHARMACEUTICALLY ACTIVE SPECIES | 2018-07-05 |
20180185287 | Formulation Obtained from a Powder Mixture Comprising an Inorganic Pigment | 2018-07-05 |
20180185288 | METHODS AND DEVICES FOR TREATING A RETINAL DETACHMENT | 2018-07-05 |
20180185289 | MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION | 2018-07-05 |
20180185290 | TRIPULSE RELEASE STIMULANT FORMULATIONS | 2018-07-05 |
20180185292 | MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION | 2018-07-05 |
20180185293 | Bacteria-Containing Oral Rapidly Disintegrating Tablet | 2018-07-05 |
20180185294 | MYCO Capsule | 2018-07-05 |
20180185295 | SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING RED YEAST RICE EXTRACT AND OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF | 2018-07-05 |
20180185296 | Biodegradable Microcapsules Containing Filling Material | 2018-07-05 |
20180185297 | Serum Specific Drug Transport System | 2018-07-05 |
20180185298 | Transdermal Adhesive Composition Comprising A Poorly Soluble Therapeutic Agent | 2018-07-05 |
20180185299 | THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA | 2018-07-05 |
20180185300 | CANNABIDIOL FOR THE PREVENTION AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 2018-07-05 |
20180185301 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | 2018-07-05 |
20180185302 | METHODS FOR DOWNREGULATING APOBEC3B | 2018-07-05 |
20180185303 | MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER | 2018-07-05 |
20180185304 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | 2018-07-05 |
20180185305 | An Amino Thiol for Use in the Treatment of an Infection Caused by the Bacterium Mycobacterium Spp | 2018-07-05 |
20180185306 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | 2018-07-05 |
20180185307 | Use of Short Chain Fatty Acids in Cancer Prevention | 2018-07-05 |
20180185308 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE OR CONDITIONS | 2018-07-05 |
20180185309 | METHODS AND COMPOSITIONS FOR TREATING NEPHROPATHY | 2018-07-05 |
20180185310 | APPLICATIONS FOR SULINDAC IN PREPARING ANTI-LUNG CANCER PRODUCTS | 2018-07-05 |
20180185311 | MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS | 2018-07-05 |
20180185312 | METHOD AND COMPOSITION FOR PREVENTING OR TREATING IMMUNE ALLERGIC AIRWAY DISEASE | 2018-07-05 |
20180185313 | COMPOSITION COMPRISING AMINO ACID AND CYCLIC DIPEPTIDE | 2018-07-05 |
20180185314 | COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF | 2018-07-05 |
20180185315 | Compositions and Methods for Diagnosis and Treatment of Anemia | 2018-07-05 |
20180185316 | Compositions and Methods for Diagnosis and Treatment of Inflammation | 2018-07-05 |
20180185317 | IMMUNOTHERAPEUTIC AGENT | 2018-07-05 |
20180185318 | COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD | 2018-07-05 |
20180185319 | PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE | 2018-07-05 |
20180185320 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2018-07-05 |
20180185321 | TALC-BOUND COMPOSITIONS AND USES THEREOF | 2018-07-05 |
20180185322 | COMPOUNDS FOR BONE HEALING | 2018-07-05 |
20180185323 | LIQUID FORMULATION OF CABAZITAXEL | 2018-07-05 |
20180185324 | NOVEL CANNABINOID COMBINATION THERAPIES FOR MULTIPLE MYELOMA (MM) | 2018-07-05 |
20180185325 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | 2018-07-05 |
20180185326 | USE OF EQUOL FOR TREATING ANDROGEN MEDIATED DISEASES | 2018-07-05 |
20180185327 | FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR | 2018-07-05 |
20180185328 | MOBILIZING AGENTS AND USES THEREFOR | 2018-07-05 |
20180185329 | COMPOSITIONS COMPRISING WATER DISPERSIBLE NANOPARTICLES OF A RETINOID COMPOUND | 2018-07-05 |
20180185330 | NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) | 2018-07-05 |
20180185331 | Method of dosing and use of soft anticholinergic esters | 2018-07-05 |
20180185332 | Leukotriene Receptor Antagonists and Their Derivatives for Use as Antibacterial Agents | 2018-07-05 |
20180185333 | METHODS OF TREATMENT ASSOCIATED WITH THE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR | 2018-07-05 |
20180185334 | COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA | 2018-07-05 |
20180185335 | COMPOSITIONS AND METHODS OF RIT1 INHIBITION | 2018-07-05 |
20180185336 | PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF | 2018-07-05 |
20180185337 | THERAPEUTIC AGENT FOR DYSLIPIDEMIA | 2018-07-05 |
20180185338 | TREATMENT OF BRCA1-DEFECTIVE CANCER OR RESISTANT CANCERS | 2018-07-05 |
20180185339 | MIRABEGRON-CONTAINING TABLET, METHOD FOR PRODUCING MIRABEGRON-CONTAINING PHARMACEUTICAL PREPARATION, AND METHOD FOR PRODUCING MIRABEGRON-CONTAINING GRANULATED PRODUCT | 2018-07-05 |
20180185340 | USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | 2018-07-05 |
20180185341 | USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS | 2018-07-05 |
20180185342 | DRUG FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE | 2018-07-05 |
20180185343 | METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS | 2018-07-05 |
20180185344 | METHODS AND COMPOSITIONS FOR PREVENTION OF FEEDLOT BOVINE RESPIRATORY DISEASE | 2018-07-05 |
20180185345 | METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS | 2018-07-05 |
20180185346 | APPLICATIONS FOR NICARDIPINE IN PREPARING ANTI-LUNG CANCER PRODUCTS | 2018-07-05 |
20180185347 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP | 2018-07-05 |
20180185348 | IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER | 2018-07-05 |
20180185349 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | 2018-07-05 |
20180185350 | RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS | 2018-07-05 |
20180185351 | THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2 | 2018-07-05 |
20180185354 | IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS | 2018-07-05 |
20180185355 | Method of Treating Dyskinesia | 2018-07-05 |
20180185356 | LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA | 2018-07-05 |
20180185357 | USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY | 2018-07-05 |
20180185358 | METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION | 2018-07-05 |
20180185359 | STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 2018-07-05 |
20180185360 | CGRP RECEPTOR ANTAGONIST COMPOUNDS FOR TOPICAL TREATMENT OF SKIN DISORDERS | 2018-07-05 |
20180185361 | METHODS FOR TREATING CANCER USING DIHYDROPYRAZINO-PYRAZINE COMPOUND COMBINATION THERAPY | 2018-07-05 |
20180185362 | METALLOENZYME INHIBITOR COMPOUNDS | 2018-07-05 |
20180185363 | PHTHALAZINONE DERIVATIVES | 2018-07-05 |
20180185364 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2018-07-05 |
20180185365 | Pharmaceutical Combinations | 2018-07-05 |
20180185366 | Inhibitors of Multidrug Resistance Transporter P-Glycoprotein | 2018-07-05 |
20180185367 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | 2018-07-05 |
20180185368 | SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | 2018-07-05 |
20180185369 | HYDROXYACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2018-07-05 |
20180185370 | PYRAZINOQUINAZOLINONE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY, METHODS AND USES THEREOF | 2018-07-05 |
20180185371 | SYSTEMS AND METHODS FOR TREATING CANCER | 2018-07-05 |
20180185372 | USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION | 2018-07-05 |